Childhood cancer survivors are at high risk for developing new cancers (such as cervical and anal cancer)
caused by persistent infection with the human papillomavirus (HPV). An effective vaccine exists that can prevent
these cancers, but uptake of the HPV vaccine is low among young cancer survivors (fewer than 1 in 4 have
received the vaccine). Lack of a healthcare provider recommendation for the HPV vaccine is the most common
reason that cancer survivors fail to get the HPV vaccine. Strategies that are most successful in increasing HPV
vaccine uptake in the general population focus on improving healthcare provider knowledge about the HPV
vaccine, enhancing the skills that healthcare providers need to effectively recommend the vaccine to young
people and their parents, and reducing barriers to receiving the vaccine. This proposed research will evaluate
the effectiveness and implementation of an evidence-based intervention, adapted for use by healthcare providers
in pediatric oncology clinics, to increase the uptake of HPV vaccine among young cancer survivors (9 to 17 years
of age and at least one year off-therapy). If the intervention is effective in improving and sustaining increased
uptake of the HPV vaccine in young cancer survivors, this study will contribute important information needed to
move forward with testing the widespread use of the intervention in pediatric oncology practices. This proposed
research addresses improving healthcare delivery and clinical outcomes for cancer survivors through prevention
of HPV-associated cancers, which are high-priority research areas for the National Cancer Institute.
If you are accessing this page during weekend or evening hours, the database may currently be offline for maintenance and should operational within a few hours. Otherwise, we have been notified of this error and will be addressing it immediately.
Please contact us
if this error persists.
We apologize for the inconvenience.
- The DCCPS Team.